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Abstract
Neurosyphilis is the progression of the untreated sexually transmitted infection caused by Treponema pallidum. When the
initial infection is not adequately treated, progression of primary syphilis can lead to a wide variety of serious health
sequelae. While neurosyphilis can appear up to 10e30 years after the initial infection, syphilis can invade the nervous
system at any stage of infection and can imitate symptoms of many other diseases. This variety of symptoms is why syphilis
has been called “The Great Pretender” or “The monkey among diseases”(Kr€
amer et al., 2018).12 This is a case report of an 83year-old female with a history of multiple TIAs, dementia, and breast cancer who presented to the emergency department
with complaints of her head “not feeling right” and intermittent ataxia (episodes of imbalance and difﬁculty ambulating)
reported by patient and patients' son. Physical exam only pertinent for chronic shufﬂing gait, but no ataxia. The patient
underwent further work-up, demonstrating negative brain imaging for cerebral vascular accident and laboratory ﬁndings
negative initially, for acute infection. An RPR was drawn as part of an broadened altered mental status workup as the patient
and family stated she was not back to baseline mental status and was positive with a quantitative titer of 1:8. Fluorescent
treponemal antibody absorption (FTA-ab) was found to be positive as well. The patient was started on three million units
intravenous Penicillin G every 4 h and was discharged with a peripherally inserted central catheter in order to receive two
weeks of Rocephin at two grams daily. Patient returned to prior baseline following completion of treatment. Through this
case, we hope to provide information on neurosyphilis and its differentiation from other disease processes and when
neurosyphilis should be suspected during an evaluation of altered mental status.
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1. Hospital course

A

n 83-year-old woman presented to the
emergency department with complaints of
intermittent ataxia (episodes of imbalance and difﬁculty ambulating), not feeling well, and “head
numbness.” The patient has a past medical history
of multiple transient ischemic attacks (TIA), dementia, breast cancer, schizoaffective disorder, diabetes mellitus, hypertension, and iron deﬁciency
anemia. Her pertinent current medications include
Celexa 10 mg daily, Furosemide 20 mg daily, Insulin
Glargine 15 units nightly, Insulin Lispro on a sliding
scale three times daily before meals, Lurasidone
80 mg daily, Quetiapine 400 mg daily, Vitamin B12
500 mcg daily, and Folic Acid 800 mcg daily.
The patient was afebrile, tachypneic at 22 breaths
per minute at an SpO2 of 96%, but otherwise

hemodynamically stable. She had no history of fall
or injury prior to the onset of her symptoms. The
patient was alert and oriented 3 and denied any
other complaints other than chronic intermittent
face numbness which was stable since her last TIA.
She denied any chest pain, shortness of breath, or
urinary complaints. Her physical exam was unremarkable and notably the patient was without ataxia
upon physical exam other than shufﬂing gait which
is present at patients’ baseline.
The initial laboratory evaluation demonstrated a
complete blood count without leukocytosis, slight
anemia with a hemoglobin of 10.7 g per deciliter, a
complete metabolic panel signiﬁcant for hypokalemia of 3.2 milliequivalents per liter and a slightly
elevated BUN of 19 mg per deciliter. She was also
hyperglycemic at 319. Urinalysis was questionable
for UTI. Her ECG was unremarkable rate of 78
beats per minute with left axis deviation and no
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signiﬁcant ST segment changes. Her chest x-ray was
unremarkable. Computerized tomography of the
head without contrast demonstrated stable chronic
ﬁndings without evidence of acute intracranial abnormality. The patient was admitted to the hospitalist service with a diagnosis of altered mental
status likely secondary to urinary tract infection
(UTI).
The patient was started on Ceftriaxone one gram
daily for UTI. Notably, in her history the patient had
had a UTI six months prior to this visit secondary to
pan-sensitive E. coli. She had also undergone an
evaluation for TIA two months prior to her current
visit. At that time her magnetic resonance imaging
demonstrated mild chronic ﬁndings with chronic
microvascular ischemic change at supratentorial
white matter without evidence for hemorrhage,
mass lesion, mass-effect, hydrocephalus or evolving
ischemia. During this current visit the patient's
urine culture returned as mixed organisms and
antibiotics were stopped due to likely contamination. A broadened medical evaluation of the patient's altered mental status was obtained, including
a rapid plasma reagin (RPR) for evaluation of
syphilis. This performed as a result of the patient/
family stating they felt the patient was not at her
baseline mental status.
On the patient's second day of hospitalization her
RPR was found to be positive. A syphilis conﬁrmatory test was ordered. Patient was discharged home
with home health with physical therapy prior to the
ﬁnal result of the conﬁrmatory test. Patient's RPR
quantitative was found to be 1:8 and FTA-Ab was
reactive. The patient was diagnosed with neurosyphilis and notiﬁed with referral to follow-up with
infectious disease as an outpatient.
Before the patient's appointment with infectious
disease she was readmitted to the hospital for
hyperosmolar hyperglycemic state. Infectious disease was consulted and the patient was started on
IV penicillin G 3,000,000 units every 4 h. Lumbar
puncture was attempted, but unable to be performed secondary to the patient's inability to lie still.
A PICC line was placed and IV penicillin G every
4 h was transitioned to ceftriaxone 2 g IV daily for
ease of administration after discharge. The patient
completed 2 weeks of antibiotics for neurosyphilis at
home with home health. Patient returned to prior
baseline following completion of treatment.

2. Discussion
The purpose of this case was to demonstrate an
example of atypical presentation of neurosyphilis
and stresses the need to include neurosyphilis in a

differential diagnosis of altered mental status, not
only for high-risk populations such as HIV positive
individuals, but also in the general population.
Those who present to the emergency department or
outpatient ofﬁce with signs and symptoms of TIA,
stroke, and/or other neuropsychiatric manifestations may have a confounding disorder like neurosyphilis. While syphilis is a reportable disease in the
United States, neurosyphilis is not, which makes
tracing incidence and prevalence challenging.13 The
most common symptoms of neurosyphilis include
headache, confusion, seizures, nausea, vomiting,
stiff neck, uveitis, vitritis, retinitis, optic neuropathy,
facial/cranial neuropathies, vestibulocochlear abnormalities, and other psychological abnormalities.2,8 On average 1 in 10 patients with
neurosyphilis present with a stroke and, although
the majority of these are patients under the age of
50, there are still a signiﬁcant amount who are older
patients.1 Even before CVA occurs, prodromal
symptoms such as headaches, vertigo, insomnia,
emotional lability, and personality changes can
occur for several months.6 Thrombosis of affected
arteries leading to cerebral infarction occurs secondary to meningovascular pathology leading to
arteritis and is not due to the CNS invasion of
Treponema pallidum.18 Cerebral infarcts most
commonly occur in the territory of the middle cerebral artery and are typically lacunar in nature.8
Movement disorders such as sensory ataxia,
parkinsonism, myoclonus, chorea, dystonia, hyperreﬂexia can result from ischemic lesions in a variety
of areas including the midbrain, cerebellum, and
basal ganglia as well.17
Many lab tests may have unclear signiﬁcance
which can further complicate a quick and accurate
diagnosis. Clinicians may struggle to conﬁdently
conﬁrm or exclude neurosyphilis because existing
deﬁnitions of neurosyphilis require evidence of invasion into the CNS but there is no available test that
is sensitive and speciﬁc enough to conﬁrm T. pallidum
invasion.19 The “gold standard” test for neurosyphilis
is the venereal disease research laboratory test (CSFVDRL) and although speciﬁc, the sensitivity is
30e70%.13 In comparison, The CSF FTA-Ab test,
while more sensitive than the former test, lacks the
same level of speciﬁcity.13 For example, CSF pleocytosis may be more speciﬁc for diagnosing neurosyphilis compared to increased CSF protein
concentration.3 In immunocompetent asymptomatic
individuals, CSF lymphocyte counts greater than 5
per liter or a concentration protein greater than
45 mg/dL is highly indicative of asymptomatic neurosyphilis.8 MRI ﬁndings such as global cortical atrophy, temporal horn widening, or dural thickening

may be seen when evaluating a patient with
CVA.3,14,21 Cerebral gummas, or dural based lesions
that look similar to meningiomas and medial temporal lobe changes that mimic herpes encephalitis
are two neuroimaging patterns that should raise
suspicion for neurosyphilis rather than CVA.13 When
looking at the MRA meningovascular syphilis speciﬁcally more often involves the supraclinoid portion
of the internal carotid artery where atherosclerotic
disease affects the common carotid bifurcation and
cavernous portion of the carotid.6 Syphilitic plaques
are long and smooth while atherosclerotic plaques
are typically shorter and irregular.6
Increased diligence of both clinical and epidemiological ﬁndings is necessary to reduce the
morbidity and mortality of neurosyphilis in patients
with neurological and cognitive symptoms along
with shortening the lengthy diagnosis time.3 Due to
the variety of symptoms surrounding syphilis
including dementia, personality changes, neurological impairments such as loss of peripheral reﬂexes and impaired vibration sense, hallucinations,
depression, and others a comprehensive interdisciplinary approach may help lead to an earlier diagnosis and less misdiagnoses.3,7,9,11,14
Early identiﬁcation of neurosyphilis is critical as
the prognosis is favorable with early treatment of
patients especially with meningeal neurosyphilis or
gummas.16 It is also imperative to select a treatment
that will ensure full compliance on the patients’ part
because the risk of neurosyphilis is increased nearly
ten-fold in those who were inadequately treated
compared to those without any treatment at all.20
The RPR titer can be linked to disease activity and a
four-time reduction in the titer does demonstrate
completed treatment.3 Partial immunity to T. pallidum is developed by the human host following
initial infection, but this is insufﬁcient to fully
eliminate the organism which leads to future
neurological infection.10 Treatment for neurosyphilis is aimed at increasing and maintaining the
antibiotic levels in the CNS during the period of
bacterial reproduction.4 Treatment was typically
with IV penicillin G 2.4 million units for 10e14
days.5,15 If patients have anaphylaxis as an allergic
reaction to penicillin and desensitization is not an
option, they may receive ceftriaxone 2 g daily for
10e14 days in replacement of penicillin4. Other
antibiotics with varying activity against syphilis
include doxycycline 100 mg twice daily for 21e30
days or macrolides 500 mg four times daily for 30
days.4 Although the above two substitutions still
need further studies and trials to show similar efﬁcacy as penicillin or ceftriaxone. Following treatment with penicillin or ceftriaxone clinical cure was
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more common than serological cure demonstrating
the need for further research into other tests to
gauge for objective treatment success.4
It is of the utmost importance to keep a broad
diagnosis when patients present with stroke-like
symptoms after TIA and strokes are ruled out in
order not to miss a life changing diagnosis or
treatment of neurosyphilis. Neurosyphilis should be
kept in the differential diagnosis when patients
present with neurological symptoms like cerebellar
ataxia since it is easily treatable.10
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